Efficacy and Safety of PF2998044 as First-line Treatment (Tx) of Patients (Pts) with Advanced (Adv) NSCLC Selected for Activating Mutation (Mu) of Epidermal Growth Factor Receptor (EGFR)
Refereed conference paper presented and published in conference proceedings

香港中文大學研究人員

全文

其它資訊
著者MOK Shu Kam Tony, SPIGEL R D, PARK K, SOCINSKI A M, TUNG Y S, KIM W D, OU I Sh, ZHANG H, OCONNELL P J, JANNE P
會議名稱35th ESMO Congress
會議國家/地區英國
會議論文集題名35th ESMO Congress
詳細描述organized by European Society for Medical Oncology,
出版年份2010
月份10
出版地United Kingdom
頁次2
語言英式英語
關鍵詞EGFR; Advanced NSCLC

上次更新時間 2018-23-01 於 18:13